Literature DB >> 10510966

Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia.

Anthony G Tsolaki1, Robert F Miller2, Ann E Wakefield1.   

Abstract

A nested PCR, amplifying a portion of the gene encoding the mitochondrial large subunit ribosomal RNA (mt LSU rRNA) of Pneumocystis carinii sp. f. hominis was applied to oropharyngeal samples obtained on repeated occasions from 12 HIV-infected patients with P. carinii pneumonia (PCP) to monitor response to anti-P. carinii treatment. Genotyping of P. carinii sp. f. hominis was also performed on paired samples of oropharyngeal and broncho-alveolar lavage samples before the start of treatment, and on oropharyngeal samples during the course of treatment, by analysis of sequence variation at the internal transcribed spacer (ITS) regions of the nuclear rRNA operon. When a simple dilutional method was used, a reduction in the amount of amplification product was observed in samples from all patients during the course of treatment. In eight of the 12 patients, a single ITS sequence type was found in the oropharyngeal samples and also in the paired broncho-alveolar lavage sample. A mixed infection was identified in the samples from three patients. In eight patients, the ITS sequence types identified in the oropharyngeal sample were the same as in the broncho-alveolar lavage sample. Nested PCR amplifying the mt LSU rRNA on oropharyngeal samples provides a non-invasive method of monitoring response to treatment of PCP. ITS sequence typing of P. carinii sp. f. hominis from oropharyngeal samples appears to be a reliable alternative to broncho-alveolar lavage samples and provides a non-invasive tool for further epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510966     DOI: 10.1099/00222615-48-10-897

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Heterogeneity of Pneumocystis sterol profiles of samples from different sites in the same pair of lungs suggests coinfection by distinct organism populations.

Authors:  Z Amit; E S Kaneshiro
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia.

Authors:  Anne Totet; Jean-Claude Pautard; Christian Raccurt; Patricia Roux; Gilles Nevez
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Population structure of rat-derived Pneumocystis carinii in Danish wild rats.

Authors:  R J Palmer; O P Settnes; J Lodal; A E Wakefield
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

5.  Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay.

Authors:  Philippe M Hauser; Jacques Bille; Cornelia Lass-Flörl; Christian Geltner; Marta Feldmesser; Michael Levi; Hitesh Patel; Victoria Muggia; Barbara Alexander; Martin Hughes; Sarah A Follett; Xiaohui Cui; Flora Leung; Gillian Morgan; Adrian Moody; David S Perlin; David W Denning
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

6.  Development and evaluation of a molecular viability assay for Pneumocystis carinii.

Authors:  N Maher; S Vermund; M Lasbury; C Lee; M Bartlett; T R Unnasch
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis infection.

Authors:  Robert F Miller; Helen E Ambrose; Vas Novelli; Ann E Wakefield
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Detection of Pneumocystis jirovecii by two staining methods and two quantitative PCR assays.

Authors:  P Rohner; V Jacomo; R Studer; J Schrenzel; J-D Graf
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

9.  Genotyping and coalescent phylogenetic analysis of Pneumocystis jiroveci from South Africa.

Authors:  Frans J L Robberts; Lynne D Liebowitz; Lynda J Chalkley
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region.

Authors:  Gilles Nevez; Anne Totet; Vincent Jounieaux; Jean-Luc Schmit; Eduardo Dei-Cas; Christian Raccurt
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.